Abstract
The aim of this study is to study the relationship between programmed cell death-1 ligand (PD-L1) and human epidermal growth receptor 2 (HER2) and the clinical–pathological features of gastric cancer (GC) and its predictive effect on the prognosis of gastric cancer (GC) patients. A retrospective analysis was performed on 113 patients undergoing GC surgery. The expression of PD-L1 and HER2 in GC and paired adjacent nontumor tissues was detected by immunohistochemistry or fluorescence in situ hybridization, and the relationships between PD-L1 and HER2 expression and clinical–pathological features and survival were analyzed by chi-square analysis, Pearson analysis, logistic regression analysis, Kaplan–Meier analysis, and Cox regression model. PD-L1 and HER2 were expressed in tumor tissues, but not in adjacent nontumor tissues. There was no correlation between the expression of PD-L1 and HER2. The expression of PD-L1 in GC was closely related to gender (p = 0.019), regional lymph node (p = 0.006), metastasis (p = 0.033), and survival status (p = 0.033), while HER2 was closely related to tumor differentiation (p = 0.033), regional lymph node (p = 0.016), and tumor–node–metastasis (TNM) stage (p = 0.036). The survival time of PD-L1-positive patients was longer than that of PD-L1-negative patients (p = 0.020). The expression of HER2 showed no difference in overall survival (p = 0.125). Multivariate analysis suggested that the TNM stage (p = 0.001) and PD-L1 expression (p = 0.047) were independent prognostic factors for survival time of GC. The expression of PD-L1 has biological significance in GC, which is closely related to the clinical–pathological characteristics and prognosis of GC patients.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
